1. Home
  2. LQDT vs IOVA Comparison

LQDT vs IOVA Comparison

Compare LQDT & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liquidity Services Inc.

LQDT

Liquidity Services Inc.

HOLD

Current Price

$31.71

Market Cap

985.8M

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$2.87

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LQDT
IOVA
Founded
1999
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
985.8M
1.0B
IPO Year
2005
2008

Fundamental Metrics

Financial Performance
Metric
LQDT
IOVA
Price
$31.71
$2.87
Analyst Decision
Buy
Buy
Analyst Count
1
12
Target Price
$40.00
$10.45
AVG Volume (30 Days)
147.6K
9.2M
Earning Date
05-14-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
38.10
32.28
EPS
0.23
N/A
Revenue
$476,669,000.00
N/A
Revenue This Year
N/A
$60.04
Revenue Next Year
N/A
$58.54
P/E Ratio
$138.46
N/A
Revenue Growth
31.20
N/A
52 Week Low
$21.67
$1.64
52 Week High
$34.97
$5.88

Technical Indicators

Market Signals
Indicator
LQDT
IOVA
Relative Strength Index (RSI) 48.97 57.08
Support Level $29.67 $2.47
Resistance Level $32.02 $2.68
Average True Range (ATR) 1.15 0.17
MACD -0.13 0.02
Stochastic Oscillator 44.54 85.48

Price Performance

Historical Comparison
LQDT
IOVA

About LQDT Liquidity Services Inc.

Liquidity Services Inc is an online auction marketplace. It manages and sells inventory and equipment for business and government clients by operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering across different product categories. The company has four reportable segments: GovDeals, Retail Supply Chain Group (RSCG), and Machinio & Software Solutions. It generates majority of its revenue from Retail Supply Chain Group (RSCG) segment which consists of marketplaces that enable corporations located in the United States and Canada to sell excess, returned, and overstocked consumer goods. Geographically, a substantial portion the company's revenue is generated from its business in United States.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: